Optimum dose study of cefozopran in the pediatric field

Japanese Journal of Antibiotics

Volumn 49, Issue 7, 1996, Pages 674-677

  Fujii, Ryocih ^a   Sunakawa, Keisuke ^a   Sato, Yoshitake ^b   Yokota, Takao ^b   Yoshimura, Kohichi ^c   Kondoh, Yasuo ^d   Kawaoi, Yasuko ^e   Terashima, Itaru ^a   Meguro, Hidenori ^b   Niinou, Kenji ^c   Toyonaga, Yoshikiyo ^d   Ishihara, Toshihide ^e   Iwai, Naoichi ^b   Nakamura, Haruhi ^a   Kuno, Kuniyoshi ^b   Miyajima, Yuuji ^b   Sakurai, Minoru ^b   Itoh, Masahiro ^e   Kawasaki, Hajime ^b   Suga, Shu ^a   Kamiya, Hitoshi ^b   Fujiwara, Takashi ^a   Inui, Takurou ^c   Taniguchi, Kiyosu ^d   Nishimura, Tadafumi ^e   Sugita, Kumiko ^a   Aoki, Shigeyuki ^b   Manago, Mitsuhiro ^a   Kobayashi, Yutaka ^b   Haruta, Tsunekazu ^c   Motohiro, Takashi ^d   Sakata, Yasutaka ^b   Matsuo, Yusaku ^e   Ono, Eiiciiiro ^a   Matsuyuki, Masakado ^b   Tsuji, Yoshiro ^a   Nakayama, Masahiko ^a   more..

^a TEIKYO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c Department of Pediatrics   (Japan)

^d Department of Pediatrics

^e TOKYO KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOZOPRAN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; EOSINOPHILIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

BACTERIAL INFECTIONS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PNEUMONIA, BACTERIAL;

EID: 0029809685     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. MIYAKE, A.; Y. YOSHIMURA, M. YAMAOKA, T. NISHIMURA, N. HASHIMOTO & A. IMADA: Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7/3-[2-(5-amino-l,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(condensed- heterocyclic azolium) methyl cephalosporins -including SCE-2787. J. Antibiotics 45: 709-720, 1992
2. IWAIII, T.; K. OKONOGI, T. YAMAZAKI, S. SHIKI, M. KONDO, A. MIYAKE & A. IMADA: In vitro and in v/vo activities of SCE-2787, a new patenterai cephalosporin with a broad antibacterial spectrum. Antimicr. -Agents & Chemoth. 36: 1358-1366, 1992
3. NAKAO, M.; Y. NOJI, T. IWAHI & T. YAMAZAKI: Antibacterial propeties of SCE-2787, a new cephem -antibiotic. J. Antimicr. Chemoth. 29: 509-518, 1992
4. FUJII, R.; T. ABE, T. TAJIMA, I. TERASHIMA, H. MEGURO, S. NAKAZAWA, H. SATO, K. NIINOU, K. SUNAKAWA, T. YOKOTA, H. AKITA, S. IWATA, Y. SATO, Y. TOYONAGA, H. NAKAMURA, K. SEO, K. KAWAMURA, K. KUNO, K. ITO, N. IWAI, H. NAKAMURA, Y. TANEDA, M. SAKURAI, M. ITO, E. AZUMA, -H. KAMIYA, K. KITAMURA, H. MIKAWA, H. KIMATA, T. NISHIMURA,.K. TABUKI, S. AOKI, M. TAKAGI, -Y. KOBAYASHI, S. TANIUCIII, Y. KOBAYASHI, T. HARUTA, K. OKURA, S. KUROKI, T. NISHIO, H. MATSUDA, K. KIDA, Y. KAINOU, T. KURASHIGE, H. MORITA, Y. KURODA, E. SHIRAKAWA, T. OKA-MOTO, T. SEKIGUCIII, Y. TSUJI, I. GONDO, N. KOBAYASHI, T. MOTOHIRO, Y. SAKATA, H. SASAKI, Y. YOSIIINAGA & S. YAMADA: Pharmacokinetics and clinical effects of cefozopran in pédiatrie patients. Jap. J. Antibiotics 49: 17-33, 1996